284 related articles for article (PubMed ID: 19226281)
1. Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1.
Heeba G; Moselhy ME; Hassan M; Khalifa M; Gryglewski R; Malinski T
Br J Pharmacol; 2009 Apr; 156(8):1256-66. PubMed ID: 19226281
[TBL] [Abstract][Full Text] [Related]
2. Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins.
Heeba G; Hassan MK; Khalifa M; Malinski T
J Cardiovasc Pharmacol; 2007 Oct; 50(4):391-8. PubMed ID: 18049306
[TBL] [Abstract][Full Text] [Related]
3. Leptin-induced endothelial dysfunction in obesity.
Korda M; Kubant R; Patton S; Malinski T
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1514-21. PubMed ID: 18689498
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction.
Mason RP; Kubant R; Heeba G; Jacob RF; Day CA; Medlin YS; Funovics P; Malinski T
Pharm Res; 2008 Aug; 25(8):1798-806. PubMed ID: 18087679
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells.
Loboda A; Jazwa A; Jozkowicz A; Dorosz J; Balla J; Molema G; Dulak J
Atherosclerosis; 2006 Jul; 187(1):26-30. PubMed ID: 16620829
[TBL] [Abstract][Full Text] [Related]
7. Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1.
Ali F; Hamdulay SS; Kinderlerer AR; Boyle JJ; Lidington EA; Yamaguchi T; Soares MP; Haskard DO; Randi AM; Mason JC
J Thromb Haemost; 2007 Dec; 5(12):2537-46. PubMed ID: 17927807
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes.
Mason RP; Corbalan JJ; Jacob RF; Dawoud H; Malinski T
J Physiol Pharmacol; 2015 Feb; 66(1):65-72. PubMed ID: 25716966
[TBL] [Abstract][Full Text] [Related]
9. Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: a link to apoptosis.
Foresti R; Sarathchandra P; Clark JE; Green CJ; Motterlini R
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):729-36. PubMed ID: 10215613
[TBL] [Abstract][Full Text] [Related]
10. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
[TBL] [Abstract][Full Text] [Related]
11. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
Antoniades C; Bakogiannis C; Leeson P; Guzik TJ; Zhang MH; Tousoulis D; Antonopoulos AS; Demosthenous M; Marinou K; Hale A; Paschalis A; Psarros C; Triantafyllou C; Bendall J; Casadei B; Stefanadis C; Channon KM
Circulation; 2011 Jul; 124(3):335-45. PubMed ID: 21730307
[TBL] [Abstract][Full Text] [Related]
12. Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature.
Parker RA; Huang Q; Tesfamariam B
Atherosclerosis; 2003 Jul; 169(1):19-29. PubMed ID: 12860247
[TBL] [Abstract][Full Text] [Related]
13. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
[TBL] [Abstract][Full Text] [Related]
14. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
15. Effects of induction/inhibition of endogenous heme oxygenase-1 on lipid metabolism, endothelial function, and atherosclerosis in rabbits on a high fat diet.
Liu D; He Z; Wu L; Fang Y
J Pharmacol Sci; 2012; 118(1):14-24. PubMed ID: 22261087
[TBL] [Abstract][Full Text] [Related]
16. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
Gong X; Ma Y; Ruan Y; Fu G; Wu S
Exp Gerontol; 2014 Apr; 52():9-17. PubMed ID: 24463049
[TBL] [Abstract][Full Text] [Related]
17. Nanomedical studies of the restoration of nitric oxide/peroxynitrite balance in dysfunctional endothelium by 1,25-dihydroxy vitamin D
Khan A; Dawoud H; Malinski T
Int J Nanomedicine; 2018; 13():455-466. PubMed ID: 29416330
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of LOX-1 by statins may relate to upregulation of eNOS.
Mehta JL; Li DY; Chen HJ; Joseph J; Romeo F
Biochem Biophys Res Commun; 2001 Dec; 289(4):857-61. PubMed ID: 11735125
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
